Nguyen V D, Griffith C N, Reus J, Barclay C, Alford S, Treat L, Hanthorn M, Ball L, Lawson L, Ledeen M, Buss J
Memorial Nephrology Associates, Olympia, WA 98506, USA.
J Vasc Access. 2008 Oct-Dec;9(4):260-8.
In 2002, the Center for Medicare and Medicaid Services (CMS) required all 18 Renal Networks to participate in a Vascular Access Quality Improvement Program (QIP). The Northwest Renal Network (NWRN 16) chose to increase arteriovenous fistula (AVF) use. NWRN 16 hypothesized that strategies which targeted the improvement of AVF rate and the reduction of catheter use were the same. In December 2001, 44.2% of hemodialysis (HD) patients in the NWRN 16 received HD using an AVF which met the Dialysis Outcome Quality Initiative (K/DOQI) 40% AVF guideline for prevalent patients. However, 43% of HD facilities (2869 patients) had less than 40% of AVF and higher HD catheter rates than the average Network catheter rates (25.0 vs. 20.3%). To address the needs of underperforming facilities, NWRN 16 provided education and tools for their vascular access decision makers to promote AVF creation and catheter reduction.
In 2002, NWRN 16 sponsored four regional workshops targeted at nephrologists, vascular surgeons, HD nurses, and interventional radiologists.
Percentage of AVFs in use in invited facilities increased from 31.3% pre-intervention to 56.2% at 4 yrs: 78% increase (99% confidence interval: 77.8% to 81.5%). Percentage of catheters increased from 25% to 25.8%: 3.2% change over 4 yrs (99% confidence interval: 2.5% to 4%).
The success of Network 16's AVF interventions demonstrates the effectiveness of Network education promoting multidisciplinary teamwork, and innovative strategies to increase dramatically AVF use without substantial increase in catheter use.
2002年,医疗保险和医疗补助服务中心(CMS)要求所有18个肾脏网络参与血管通路质量改进计划(QIP)。西北肾脏网络(NWRN 16)选择增加动静脉内瘘(AVF)的使用。NWRN 16假设,旨在提高AVF使用率和减少导管使用的策略是相同的。2001年12月,NWRN 16中44.2%的血液透析(HD)患者使用符合透析结果质量倡议(K/DOQI)中针对现患患者40% AVF指南的AVF进行HD治疗。然而,43%的HD机构(2869名患者)的AVF使用率低于40%,且HD导管使用率高于网络平均导管使用率(25.0%对20.3%)。为满足表现不佳机构的需求,NWRN 16为其血管通路决策者提供教育和工具,以促进AVF的建立和减少导管使用。
2002年,NWRN 16主办了四次针对肾病学家、血管外科医生、HD护士和介入放射科医生的区域研讨会。
受邀机构中使用的AVF百分比从干预前的31.3%增加到4年后的56.2%:增加了78%(99%置信区间:77.8%至81.5%)。导管百分比从25%增加到25.8%:4年变化3.2%(99%置信区间:2.5%至4%)。
网络16的AVF干预措施的成功证明了网络教育促进多学科团队合作的有效性,以及在不大量增加导管使用的情况下大幅增加AVF使用的创新策略。